Related Experiment Videos
Regulating preimplantation genetic diagnosis--how to control PGD
1The 1st Department of Obstetrics and Gynecology, TOHO University School of Medicine, 6-11-1 Ohmori-Nishi, Ohta-Ku, Tokyo 143-8541, Japan. ntakesit@med.toho-u.ac.jp
Journal of Assisted Reproduction and Genetics
|April 22, 2004
Summary
Currently, no specific regulations govern Preimplantation Genetic Diagnosis (PGD) globally or in Japan. Establishing clear guidelines and licensing is crucial for this advanced reproductive technology.
Area of Science:
- Reproductive Medicine
- Human Genetics
- Bioethics
Background:
- Preimplantation Genetic Diagnosis (PGD) involves complex techniques requiring specialized knowledge.
- The absence of standardized global regulations poses challenges for PGD implementation.
Purpose of the Study:
- To evaluate existing regulations for Preimplantation Genetic Diagnosis (PGD).
- To determine the necessity of specific licensing procedures for PGD.
- To explore methods for regulating and controlling PGD.
Main Methods:
- Review of organizational statements and guidelines from the Japan Society of Obstetrics and Gynecology (JSOG).
- Assessment of statements from the Japan Society of Human Genetics regarding genetic disease diagnosis.
- Discussion of licensing and qualification requirements for PGD laboratories, staff, and directors.
Main Results:
- No current regulations specifically govern PGD laboratories, scientists, directors, or staff.
- Regulations are country-specific, with no unified international system.
- Japan is actively considering the development of PGD regulations within reproductive and genetic fields.
Conclusions:
- PGD demands high-level technical skills and extensive knowledge of genetic diseases.
- Achieving near-perfect diagnostic accuracy is essential, despite inherent risks with small sample sizes.
- Specialized expertise in reproduction and genetics is mandatory for PGD practitioners.